Other
Blood Loss During Surgery
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Blood Loss During Surgery is an early-stage landscape with 0 programs across 1 company. The most active players are Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
1
clinical trials
Completed1 · 100%
Clinical Trials
Trial Activity
A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery.
Completed·
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.·Phase 2/3·NCT00270023·112 enrolled
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.·Phase 2/3·NCT00270023·112 enrolledData sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)